Eighteen stenotic aortic valves (17 removed at operation) mounted in a pulsatile flow duplicator were dilated with a balloon catheter. Sequential measurements showed that the valve area initially increased from a mean (SD) of 052 (0-16) to 0-78 (0-17) cm2. It wai (0-16) cm2 five minutes after dilatation and this was little changed at four weeks (0 70 (0-15) Both the procedural and methodological limitations to haemodynamic assessment have contributed to uncertainty about the real and apparent effects of the procedure. Intraoperative simulation was limited to single measurements before and after dilatation6 and like most in vitro studies"213 did not measure areas and gradients during flow. We performed balloon dilatation in 18 stenotic human aortic valves mounted in a pulsatile flow duplicator and measured the sequential changes in area and gradient without the constraints present in clinical practice.
Percutaneous balloon dilatation of the aortic valve in elderly patients with calcific aortic stenosis deemed to be at high risk from conventional operation was first described as a palliative procedure by Cribier et al and McKay et al in 1986.' 2 Their initial encouraging reports were soon followed by larger studies with more impressive results." Other reports suggested only a very limited effect from balloon dilatation6 and provided evidence of a rapid loss of any haemodynamic improvement.7 Recent studies showed that more than half the patients had died, undergone valve replacement or redilatation, or had a recurrence of symptoms at mean follow up periods of 5-8 months"' and the value of the procedure remains uncertain.
Haemodynamic evaluation of dilatation of the aortic valve is confounded by several procedural factors including myocardial depression during balloon inflation, haemorrhage, arrhythmias, and vagal effects. Aortic valve area estimations by the Gorlin formula may be unreliable at discriminating small changes, especially in patients with low cardiac outputs, and the timing of non-invasive assessments has varied between studies.
Both the procedural and methodological limitations to haemodynamic assessment have contributed to uncertainty about the real and apparent effects of the procedure. Intraoperative simulation was limited to single measurements before and after dilatation6 and like most in vitro studies"213 did not measure areas and gradients during flow. We performed balloon dilatation in 18 stenotic human aortic valves mounted in a pulsatile flow duplicator and measured the sequential changes in area and gradient without the constraints present in clinical practice.
Patients and methods

VALVES
Of the 18 valves, seventeen were removed intact at aortic valve operation and one at routine necropsy. Fourteen valves were stored in 10% formaldehyde while four were used fresh from operation and thereafter stored in homograft valve nutrient solution."4 Preoperative peak to peak catheter gradients ranged from 50 to 130 mm Hg and significant aortic regurgitation was present in only three patients. Eleven valves were bicuspid, six tricuspid, and one unicuspid. In two patients percutaneous balloon dilatation had been performed without sustained symptomatic improvement (table 1) . seen from the side view. The balloon was inflated to 3 atmospheres (303 kPa) (manufacturer's limit) during continuous video recording. When obvious commissural tearing occurred the balloon was deflated after 30 seconds; otherwise inflation was maintained for a full minute. During inflation the circulation was temporarily stopped to avoid pressure overload to the circuitry and valve and the circulation was restarted on deflation. Five seconds after the flow had been re-established we measured the valve area and gradient. These measurements were repeated at 5, 10, 15, 20, 25, 30, 60, and 120 minutes while the flow was maintained continuously. The valve was removed from the chamber and stored in the appropriate medium. At 24, 48, and 72 hours and at 1, 2, and 4 weeks the valve was returned to the test chamber and, after 30 minutes of flow, the area and gradient were measured as before. In two valves complete data were not obtained and in one video recordings were inadvertently erased during subsequent recordings.
RADIOGRAPHY
Valves were examined by projection microradiography with a Hilger Watts generator (London) before and after balloon dilatation. The images produced were 3-5 times real size and showed the calcific deposits in fine detail.
DATA ANALYSIS
Changes in valve area and mean pressure gradient were investigated by an analysis of variance for repeated measures with a Genstat Package on the University of London main frame computer. The results are expressed as means (SD) and a p value <0 01 was considered statistically significant.
Results
AREA AND GRADIENT CHANGES
There was an increase in valve area and decrease in the mean pressure gradient across all the valves studied (table 1). The aortic valve area increased from 0-52 (0-16) cm2 to 0-78 (0-17) cm2 immediately after balloon dilatation (p < 0 001) but had fallen to 0-73 (0-16) cm2 five minutes after the procedure (p < 0 01). Thereafter there were no significant changes in valve area and at four weeks the area measured 0-70 (0-15) cm2-35% more than before dilatation. The mean transvalvar pressure gradient fell from 54 (27) mm Hg to 33 (8) Leaflet recoil caused an early fall in valve area and only later a rise in gradient. The supravalvar pressure port in this model is at a fixed distance from the retaining plates that hold the cones, and the distance from the valve to the pressure port varied according to the length of cone left after it was cut down to accommodate the valve annulus area. The distance was nearly always greater than a halfof the orifice diameter'5-that is the distance at which the pressure drop is lowest (vena contracta)-so that slight though systematic under reading of the gradients may have reduced the extent of the early changes. The valve area, however, is not the only factor to determine the gradient-orifice geometry and depth are other factors.25 The orifice depth is likely to have increased as the stretching displaced leaflet material and reduced the expected fall in the gradient; recoil of the leaflet thickening would then have offset the rise in gradient. Most ofthe valves were preserved in formalin-a storage medium used by others for valve dilatation studies"2 1 26-and the effects of formalin may provide an alternative explanation for the gradient changes. We have previously shown that the valve area and gradient measured over a wide range of flows does not change within a month of explantation and storage in either formalin or nutrient solution."5 Nevertheless formalin storage may have had an effect on the gradient measured across dilated valves, though the four valves used fresh from surgery (and thereafter stored in nutrient solution) behaved in a similar fashion.
CONCLUSIONS
We found significant though rather small increases in valve area after balloon dilatation of calcific stenotic aortic valves. Commissural splitting seemed to increase the orifice area more than stretching alone, but fractures of calcific deposits unrelated to commissures were uncommon. Stretching of the valve orifice was followed by a measurable recoil within the first five minutes, irrespective of coexistent commissural splitting. Thereafter, and in the absence of any reparative mechanisms that might be present in vivo, there were no significant changes in valve area over the succeeding four weeks. Assessment of balloon dilatation of the aortic valve in the clinical setting should be performed only when the patient is stable and all the procedural effects can be discounted. In that way it might be possible accurately to document the real effects of the procedure. The changes that we saw suggest that patients who are critically compromised by aortic stenosis may benefit from balloon dilatation. In most patients, however, the improvement in valve area is unlikely to be adequate for definitive treatment.
